Stay updated on HepTcell Immunotherapy in Inactive CHB Clinical Trial

Sign up to get notified when there's something new on the HepTcell Immunotherapy in Inactive CHB Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the HepTcell Immunotherapy in Inactive CHB Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The record now presents details for the Phase 2 HepTcell study, including its terminated status, study design and outcomes, eligibility criteria, participating locations, and posted study documents.
    Difference
    52%
    Check dated 2026-11-11T01:00:31.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changed from v3.7.2 to v3.8.0; the study record still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T23:15:00.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    An NIH notice about its terminology transition appears above the ClinicalTrials.gov page, and the site revision identifier changes. The study record itself still displays a 403 error.
    Difference
    1%
    Check dated 2026-10-20T22:49:14.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The site footer’s revision number advances from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-06T23:03:43.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    403 Forbidden error is displayed, indicating the page is currently inaccessible. The usual study details and navigation are replaced by an error screen.
    Difference
    17%
    Check dated 2026-09-22T23:06:11.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    Added a new Revision: v3.7.0 tag and removed Revision: v3.6.6, indicating a platform version update. This reflects an update to the page's underlying software rather than changes to the study details.
    Difference
    0.1%
    Check dated 2026-09-15T21:42:35.000Z thumbnail image

Stay in the know with updates to HepTcell Immunotherapy in Inactive CHB Clinical Trial

Enter your email address, and we'll notify you when there's something new on the HepTcell Immunotherapy in Inactive CHB Clinical Trial page.